Indonesia OKs Sinopharm COVID-19 vaccine for emergency use | Inquirer News
Close  

Indonesia OKs Sinopharm COVID-19 vaccine for emergency use

/ 02:41 PM April 30, 2021
A nurse holds a syringe containing a coronavirus disease (COVID-19) vaccine by Sinopharm at a vaccination center in Beijing

FILE PHOTO: A nurse holds a syringe containing a coronavirus disease (COVID-19) vaccine made by the Beijing Institute of Biological Products, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), at a vaccination center during a government-organized visit, in Beijing, China, April 15, 2021. REUTERS/Thomas Peter

JAKARTA — Indonesia’s drug regulator on Friday approved the COVID-19 vaccine of China’s Sinopharm, which it will use in a private immunization scheme where companies buy government-procured vaccines to inoculate their staff.

After Sinovac Biotech and AstraZeneca, Sinopharm is the third company to have its vaccine approved by Indonesia, which is seeking to inoculate 181.5 million people by January 2022.

ADVERTISEMENT

It has suffered one of the worst COVID-19 outbreaks in Asia, with 1.66 million infections and more than 45,000 deaths reported.

Penny K. Lukito, chief of Indonesia’s food and drug agency (BPOM), said Sinopharm vaccine recipients had reported higher antibody rates and rare side effects, such as swelling or diarrhea.

FEATURED STORIES

“Based on the evaluation and the benefits or risks consideration … BPOM has issued an emergency use authorisation (for Sinopharm),” she told a news conference.

Verdi Budidarmo, CEO of pharmaceutical company Kimia Farma which distributes the vaccine, said the private vaccination programme, which starts next month, could “back up the government to reach herd immunity”.

No detailed efficacy data of Sinopharm’s vaccine has been publicly released.

However, its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group, has said the vaccine was 79.34% effective in preventing people from developing the disease, based on interim data.

Indonesia’s vaccine program has slowed due to an export ban from India and other supply issues, although health minister Budi Gunadi Sadikin said he hoped it could get back on track in May.

It has administered at least one shot of COVID-19 vaccine to about 12.3 million of its 270 million population.

The country received 3.85 million doses of the AstraZeneca vaccine this week and Budi said 10 million to 15 million additional doses of the Sinovac vaccine would be received in the next few weeks.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus pandemic, emergency use authorization (EUA), Indonesia, Sinopharm
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.